The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis
- PMID: 19002570
- DOI: 10.1007/s10911-008-9097-1
The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis
Abstract
Insulin-like growth factor-I and -II (IGF-I and IGF-II) and/or the type I insulin-like growth factor receptor (IGF-IR) have been implicated in a number of human tumors including breast cancer. However, despite being implicated in breast cancer for approximately 25 years and given that transgenic technology has been available for about the same period of time, it is surprising that transgenic mice overexpressing the IGF-IR in the mammary gland have only recently been characterized. This review will describe the effects of IGF-IR overexpression on mammary ductal morphogenesis and mammary tumorigenesis in the two available transgenic models.
Similar articles
-
IGF-IR mediated mammary tumorigenesis is enhanced during pubertal development.PLoS One. 2014 Sep 26;9(9):e108781. doi: 10.1371/journal.pone.0108781. eCollection 2014. PLoS One. 2014. PMID: 25259518 Free PMC article.
-
Insulin receptor substrates (IRSs) and breast tumorigenesis.J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):415-22. doi: 10.1007/s10911-008-9101-9. Epub 2008 Nov 22. J Mammary Gland Biol Neoplasia. 2008. PMID: 19030971 Free PMC article. Review.
-
The IGF system in mammary development and breast cancer. Preface.J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):351-2. doi: 10.1007/s10911-008-9096-2. J Mammary Gland Biol Neoplasia. 2008. PMID: 19030973 No abstract available.
-
Developmental changes in insulin-like growth factor I receptor gene expression in the mouse mammary gland.Endocr Res. 2004 Feb;30(1):127-40. doi: 10.1081/erc-120029892. Endocr Res. 2004. PMID: 15098926
-
Noncanonical TGF-β signaling during mammary tumorigenesis.J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):127-46. doi: 10.1007/s10911-011-9207-3. Epub 2011 Mar 31. J Mammary Gland Biol Neoplasia. 2011. PMID: 21448580 Free PMC article. Review.
Cited by
-
ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis.Mol Cancer. 2010 Sep 8;9:235. doi: 10.1186/1476-4598-9-235. Mol Cancer. 2010. PMID: 20825649 Free PMC article.
-
Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions.Nucl Recept Signal. 2014 Nov 4;12:e004. doi: 10.1621/nrs.12004. eCollection 2014. Nucl Recept Signal. 2014. PMID: 25422594 Free PMC article.
-
Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.Tumour Biol. 2014 Mar;35(3):2035-45. doi: 10.1007/s13277-013-1270-5. Epub 2013 Oct 5. Tumour Biol. 2014. PMID: 24096546
-
Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231.J Biol Chem. 2010 Nov 26;285(48):37458-66. doi: 10.1074/jbc.M110.163329. Epub 2010 Sep 13. J Biol Chem. 2010. PMID: 20837466 Free PMC article.
-
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.Breast Cancer Res Treat. 2020 May;181(1):61-68. doi: 10.1007/s10549-020-05596-4. Epub 2020 Mar 21. Breast Cancer Res Treat. 2020. PMID: 32200486
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical